Joseph Young
Comptroller/Controller/Auditor at VERA THERAPEUTICS, INC.
Net worth: 2 M $ as of 31/05/2024
Network origin in Joseph Young first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 21 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Joseph Young via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Biotechnology | General Counsel | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | General Counsel | |
RainDance Technologies, Inc.
 RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | Medical Specialties | Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| APELLIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
Kleiner Perkins Caufield & Byers LLC
 Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers LLC (Kleiner Perkins Caufield & Byers) is a venture capital firm founded in 1972 by Eugene Kleiner, Thomas Perkins, Brook Byers and Frank J. Caufield. The firm is headquartered in California, US. | Investment Managers | Consultant / Advisor | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Private Equity Investor | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Facet, Inc.
 Facet, Inc. Information Technology ServicesTechnology Services Facet, Inc. manufactures software for creating and maintaining libraries. The private company is based in Milwaukee, WI and has no subsidiaries. | Information Technology Services | Director/Board Member | |
| McGill University | College/University | Doctorate Degree | |
| The California State University | College/University | Undergraduate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree Undergraduate Degree | |
Resonant Medical, Inc.
 Resonant Medical, Inc. Medical SpecialtiesHealth Technology Resonant Medical Inc. develops, manufactures and distributes 3D ultrasound image-guided adaptive radiotherapy products. The company was founded by Fred Francis, Tony Falco and Luc Sirois and is headquartered in Montréal, CA. | Medical Specialties | Corporate Officer/Principal | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member | |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Chief Executive Officer | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Miscellaneous Commercial Services | Director/Board Member | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
| VAXCYTE, INC. | Biotechnology | Director/Board Member Chairman | |
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Orionis Biosciences, Inc.
 Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | Packaged Software | Chief Tech/Sci/R&D Officer | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sectoral Asset Management Inc (Private Equity)
 Sectoral Asset Management Inc (Private Equity) Investment ManagersFinance Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec. | Investment Managers | Private Equity Investor | |
| Ascendis Pharma, Inc. | Director/Board Member | ||
| AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member | |
| Exactis Innovation | Chairman | ||
| AEROVATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
T2C2 Capital
 T2C2 Capital Financial ConglomeratesFinance T2C2 Capital provides investment services. | Financial Conglomerates | Corporate Officer/Principal | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member | |
Boys & Girls Clubs of Metro Los Angeles
 Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Boys & Girls Clubs of Metro Los Angeles is a non-profit organization that was founded in December 2015 to provide a sustainable solution to the opportunity crises facing vulnerable children in the neediest neighborhoods of Los Angeles. Boys & Girls Clubs of Metro Los Angeles is based in Los Angeles, CA, and has subsidiaries in the United States. The organization operates four clubs in Bell Gardens, Challengers, Downs, and Willowbrook, and offers nationally recognized, research-based programs and activities in three core areas: academic success, good character and citizenship, and healthy lifestyles. The organization empowers youth to explore a future with endless possibilities by offering creative programming, such as new approaches to science, technology, engineering, and math (STEM) created in collaboration with community partners. The non-profit company was founded in 2015, and the CEO is Patrick Mahoney. | Miscellaneous Commercial Services | Director/Board Member | |
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Biotechnology | Director/Board Member | |
Launch Therapeutics, Inc.
 Launch Therapeutics, Inc. Financial ConglomeratesFinance Launch Therapeutics, Inc. provides investment and therapies development services. The CEO of the American company is Anshul Thakral. | Financial Conglomerates | Director/Board Member |
Statistics
International
| United States | 37 |
| Canada | 11 |
| United Kingdom | 4 |
Sectoral
| Health Technology | 27 |
| Finance | 9 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Technology Services | 3 |
Operational
| Director/Board Member | 120 |
| Corporate Officer/Principal | 37 |
| Independent Dir/Board Member | 36 |
| Undergraduate Degree | 19 |
| Private Equity Investor | 14 |
Most connected contacts
| Insiders | |
|---|---|
| Patrick Enright | 41 |
| Beth Seidenberg | 39 |
| Kurt von Emster | 34 |
| Maha Katabi | 28 |
| Scott Morrison | 16 |
| Andrew Cheng | 10 |
| Jonathan R. Wolter | 9 |
| Robert M. Brenner | 8 |
| Michael Morrissey | 8 |
| Kimball Hall | 7 |
| William D. Turner | 7 |
| Marshall Fordyce | 6 |
| Sean Grant | 5 |
| Kelly Rauber | 5 |
| Kerry Cooper | 5 |
- Stock Market
- Insiders
- Joseph Young
- Company connections
